Krka, d. d. (WSE:KRK)

Market Cap	21.69B
Revenue (ttm)	8.17B
Net Income (ttm)	1.53B
Shares Out	n/a
EPS (ttm)	49.64
PE Ratio	14.20
Forward PE	n/a
Dividend	32.10 (4.46%)
Ex-Dividend Date	Jul 23, 2024

Volume	120
Average Volume	47
Open	750.00
Previous Close	720.00
Day's Range	714.00 - 750.00
52-Week Range	522.00 - 750.00
Beta	0.51
RSI	58.68
Earnings Date	Apr 10, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases. The company provides non-prescription products for oral cavity and pharynx; cough and cold; analge...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 12,810
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial numbers in EUR